Hepatitis B Virus Therapy
New findings in hepatitis B virus therapy described from Chang-Gung University, Department of Dermatology
Published in Drug Week, October 5th, 2007
Research findings, "Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy," are discussed in a new report. "The potentially fatal complications associated with viral hepatitis B (HBV) reactivation have not been characterized in bullous/connective tissue disease patients receiving prolonged systemic glucocorticosteroids (GCs). This study reports HBV reactivation following GC therapy for a case series of pemphigus vulgaris and dermatomyositis," scientists writing in the British Journal of Dermatology report.
"The retrospective study cohort comprised 98 patients who received at least 6 months of systemic GC...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-10-05)
More Articles from Drug Week
- Addiction Medicine
New genetic research into nicotine addiction shows promise for personalized treatment - Amyotrophic Lateral Sclerosis
U. Iowa team identifies genes that improve survival in mice with ALS - Biomedicine
Research Explains Link Between Cholesterol and Heart Disease - Biopharmaceuticals
Using green chemistry to deliver cutting-edge drugs - Brain Cancer
Study suggests brain tumors need treatment with multiple 'targeted' drugs - Breast Cancer
Linchpin gene may be useful target for new breast cancer therapies - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
